Bank Of America Corp Marker Therapeutics, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.24 - $4.58 $25 - $480	105 Added 2.1%	5,107 $1,000
Q1 2022 May 16, 2022	BUY	$0.37 - $1.0 $518 - $1,400	1,400 Added 38.87%	5,002 $2,000
Q4 2021 Feb 08, 2022	SELL	$0.95 - $1.72 $6,844 - $12,392	-7,205 Reduced 66.67%	3,602 $4,000
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $16,553 - $28,376	-9,853 Reduced 47.69%	10,807 $18,000
Q2 2021 Sep 13, 2021	BUY	$1.88 - $3.56 $38,840 - $73,549	20,660 New	20,660 $58,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $259M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.